{
    "id": "54521497",
    "revid": "7903804",
    "url": "https://en.wikipedia.org/wiki?curid=54521497",
    "title": "N-Desmethylenzalutamide",
    "text": "\"N\"-Desmethylenzalutamide is a &lt;a href=\"nonsteroidal%20antiandrogen\"&gt;nonsteroidal antiandrogen&lt;/a&gt; (NSAA) and the major &lt;a href=\"metabolite\"&gt;metabolite&lt;/a&gt; of &lt;a href=\"enzalutamide\"&gt;enzalutamide&lt;/a&gt;, an NSAA which is used as a &lt;a href=\"hormonal%20antineoplastic%20agent\"&gt;hormonal antineoplastic agent&lt;/a&gt; in the treatment of &lt;a href=\"metastatic\"&gt;metastatic&lt;/a&gt; &lt;a href=\"prostate%20cancer\"&gt;prostate cancer&lt;/a&gt;. It has similar activity to that of enzalutamide and, with enzalutamide therapy, circulates at similar concentrations to those of enzalutamide at &lt;a href=\"steady%20state%20%28pharmacokinetics%29\"&gt;steady state&lt;/a&gt;. \"N\"-Desmethylenzalutamide is formed from enzalutamide in the &lt;a href=\"liver\"&gt;liver&lt;/a&gt; by the &lt;a href=\"cytochrome%20P450\"&gt;cytochrome P450&lt;/a&gt; &lt;a href=\"enzyme\"&gt;enzyme&lt;/a&gt;s &lt;a href=\"CYP2C8\"&gt;CYP2C8&lt;/a&gt; and &lt;a href=\"CYP3A4\"&gt;CYP3A4&lt;/a&gt;. It has a longer &lt;a href=\"terminal%20half-life\"&gt;terminal half-life&lt;/a&gt; than enzalutamide (7.8\u00a0days versus 5.8\u00a0days)."
}